Randomized Phase III Study of Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer After Platinum-Based Therapy.
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2013
At a glance
- Drugs Cetuximab (Primary) ; Docetaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms SELECT
- Sponsors Eli Lilly; ImClone Systems
- 11 Nov 2013 Results published in Lancet Oncology.
- 11 Jun 2012 Status changed from active, no longer recruiting to completed.
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History